Unknown PHASE2 INTERVENTIONAL NCT00826891

Study of Cisplatin in Cervical Cancer Stage IVB

Phase II Study of Cisplatin Combined With Topotecan in Advanced (Stage IVB) Recurrent or Persistent Cervical Cancer

Sponsor: Chinese Anti-Cancer Association

Interventions Cisplatin Combined With Topotecan

Updated 5 times since 2017 Last updated: Jan 20, 2009 Started: Feb 28, 2009 Primary completion: Jan 31, 2010 Completion: Jan 31, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cervical Cancer, this trial is ongoing. The trial is conducted by Chinese Anti-Cancer Association and has accumulated 5 data snapshots since 2009. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese Anti-Cancer Association

Data source: Chinese Anti-Cancer Association

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.